Why Glaucoma Matters
Glaucoma encompasses conditions that damage the optic nerve, often without warning. Because vision loss is irreversible, managing intraocular pressure—the only modifiable risk factor—is vital for successful prevention and sight preservation.
Many communities lack access to reliable intraocular pressure measurement and specialist eye care. AndEye is being developed to help bring accessible glaucoma screening closer to the people who need it most.
Often Silent
Glaucoma may progress before patients notice any change in vision.
Vision Loss Is Irreversible
Early identification is critical to protecting remaining sight.
Access Remains Unequal
Many underserved communities lack practical diagnostic equipment.
TECHNICAL BLUEPRINT
Precision Engineering
We are developing a proprietary indentation-based sensing system designed to measure intraocular pressure accurately and consistently, and to expand access to reliable intraocular pressure measurement.
Indentation Sensing
Controlled micro-mechanical sensing designed to deliver accurate and repeatable pressure measurements.
Designed for Low-Resource Settings
A lightweight, battery-powered platform designed for clinics with limited infrastructure and resources.
The Handheld Advantage
PORTABLE BY DESIGN
Built for Mobility
A compact, battery-powered platform designed for use in clinics, outreach programmes and resource-limited settings.
INTUITIVE OPERATION
Simplified Measurement
A streamlined interface designed to reduce training requirements and support efficient intraocular pressure measurement.
BUILT FOR ACCESS
Closing the Care Gap
Engineered with affordability and durability in mind to extend glaucoma screening to underserved and remote communities.
Collaborate With Us
PARTNERSHIPS
We welcome conversations with clinical collaborators, engineers, manufacturers, funders and organisations working to improve access to eye care.
Communication
contact@andeyemedical.com
Currently in Development
AndEye’s handheld tonometer is currently undergoing prototype development. Its performance, usability and safety will be evaluated through structured technical and clinical validation before regulatory submission and commercial release.
Concept
AndEye’s technology is currently under development and is not yet approved for clinical use. Product specifications and features may change during validation.
Prototype Development
Validation
Regulatory Approval
Clinical Deployment
Our Team
Dr Sean Glen Anderson
Co-Founder & Clinical Lead
Sean is an ophthalmology registrar and clinical researcher focused on glaucoma diagnostics and accessible eye care. His research into low-cost intraocular pressure measurement led to the founding of AndEye and continues to guide the device’s clinical development.
Dr Craig Dean Anderson
Co-Founder & Clinical Advisor
Craig is a specialist ophthalmologist who has recently begun a glaucoma fellowship in Canada. He brings specialised clinical insight and practical experience to help ensure AndEye’s technology addresses the real-world needs of clinicians and patients.